Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal TrialStephan Stilgenbauer, William G. Wierda, John F. Seymour et al.|Journal of Clinical Oncology|2018Cited by 313
Long-term Follow-up of Patients with Relapsed or Refractory Non–Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human StudyMatthew S. Davids, John F. Seymour, Andrew W. Roberts et al.|Clinical Cancer Research|2021Cited by 69